212 related articles for article (PubMed ID: 33111873)
1. COVID-19, Renin-Angiotensin System, Angiotensin-Converting Enzyme 2, and Nicotine: What is the Interrelation?
Scholz JR; Lopes MACQ; Saraiva JFK; Colombo FC
Arq Bras Cardiol; 2020 Oct; 115(4):708-711. PubMed ID: 33111873
[No Abstract] [Full Text] [Related]
2. Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?
Silhol F; Sarlon G; Deharo JC; Vaïsse B
Hypertens Res; 2020 Aug; 43(8):854-856. PubMed ID: 32439915
[No Abstract] [Full Text] [Related]
3. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
Speth RC
Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
[No Abstract] [Full Text] [Related]
4. A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19.
Usman MS; Siddiqi TJ; Khan MS; Ahmed A; Ali SS; Michos ED; Hall ME; Krasuski RA; Greene SJ; Butler J; Alkhouli M
Am J Cardiol; 2020 Sep; 130():159-161. PubMed ID: 32624189
[No Abstract] [Full Text] [Related]
5. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
Delpino MV; Quarleri J
Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170
[No Abstract] [Full Text] [Related]
6. COVID-19: The heart of the issue.
Woodward B; Kermali M
J Card Surg; 2020 Aug; 35(8):2112. PubMed ID: 32542802
[No Abstract] [Full Text] [Related]
7. Covid-19: the renin-angiotensin system imbalance hypothesis.
Lanza K; Perez LG; Costa LB; Cordeiro TM; Palmeira VA; Ribeiro VT; Simões E Silva AC
Clin Sci (Lond); 2020 Jun; 134(11):1259-1264. PubMed ID: 32507883
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19.
Gue YX; Kanji R; Markides V; Gorog DA
Am J Cardiol; 2020 Sep; 130():161-162. PubMed ID: 32636018
[No Abstract] [Full Text] [Related]
9. SARS-CoV-2 & Covid-19: Key-Roles of the 'Renin-Angiotensin' System / Vitamin D Impacting Drug and Vaccine Developments.
Cao Z; Wu Y; Faucon E; Sabatier JM
Infect Disord Drug Targets; 2020; 20(3):348-349. PubMed ID: 32370727
[No Abstract] [Full Text] [Related]
10. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.
Vaduganathan M; Vardeny O; Michel T; McMurray JJV; Pfeffer MA; Solomon SD
N Engl J Med; 2020 Apr; 382(17):1653-1659. PubMed ID: 32227760
[No Abstract] [Full Text] [Related]
11. [Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].
Kreutz R; Abd El-Hady Algharably E; Ganten D; Messerli F
Pneumologie; 2020 Sep; 74(9):611-614. PubMed ID: 32916743
[No Abstract] [Full Text] [Related]
12. [ACE2 and coronavirus - a question of balance and dynamics?].
Lundström A; Sandén P
Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular disease and the impact of COVID-19.
Yoganathan A; Sajjad MS; Harky A
J Card Surg; 2020 Aug; 35(8):2113. PubMed ID: 32542799
[No Abstract] [Full Text] [Related]
14. COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.
Siniorakis E; Arvanitakis S; Nikolopoulos I; Elkouris M
mBio; 2020 May; 11(3):. PubMed ID: 32444383
[No Abstract] [Full Text] [Related]
15. Reply to: 'Interaction between RAAS inhibitors and ACE2 in the context of COVID-19'.
Zheng YY; Ma YT; Zhang JY; Xie X
Nat Rev Cardiol; 2020 May; 17(5):313-314. PubMed ID: 32231330
[No Abstract] [Full Text] [Related]
16. Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2?
Patel AB; Verma A
Clin Infect Dis; 2020 Nov; 71(16):2129-2131. PubMed ID: 32442259
[No Abstract] [Full Text] [Related]
17. Covid-19 and the angiotensin-converting enzyme (ACE2): Areas for research.
Omar MB
Heart Lung; 2020; 49(4):351. PubMed ID: 32327200
[No Abstract] [Full Text] [Related]
18. COVID-19 and the pulmonary vascular injury.
Dai HL; Guang XF
J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972276. PubMed ID: 33176538
[No Abstract] [Full Text] [Related]
19. COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?
Şen S; Üresin AY
Turk Kardiyol Dern Ars; 2020 Oct; 48(7):631-634. PubMed ID: 33034579
[No Abstract] [Full Text] [Related]
20. Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension.
Cure E; Cumhur Cure M; Vatansev H
J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972015. PubMed ID: 33169637
[No Abstract] [Full Text] [Related]
[Next] [New Search]
